ACTON, Mass.--(BUSINESS WIRE)--Jul. 24, 2019--
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming investor conferences:
The 39th Annual Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 7, 2019, at 2:30 p.m. (Eastern Time).
The Baird 2019 Global Healthcare Conference in New York City, NY on Thursday, September 5, 2019, at 8:30 a.m. (Eastern Time).
The 17th Annual Morgan Stanley Global Healthcare Conference in New York City, NY on Tuesday, September 10, 2019, at 11:45 a.m. (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.myomnipod.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190724005638/en/
Source: Insulet Corporation
Investor Relations and Media Contact:
Deborah R. Gordon
Vice President, Investor Relations and Corporate Communications